CHARLES SCHWAB INVESTMENT MANAGEMENT INC - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,558,082
-0.1%
246,681
+37.9%
0.00%0.0%
Q2 2023$2,561,418
+109.0%
178,870
+4.2%
0.00%
Q1 2023$1,225,274
-37.0%
171,607
-1.0%
0.00%
-100.0%
Q4 2022$1,943,910
+11.9%
173,254
+10.6%
0.00%0.0%
Q3 2022$1,737,000
+71.6%
156,680
+30.8%
0.00%
Q2 2022$1,012,000
-41.1%
119,814
-5.1%
0.00%
-100.0%
Q1 2022$1,718,000
-29.2%
126,187
+2.3%
0.00%0.0%
Q4 2021$2,426,000
-37.5%
123,299
+2.0%
0.00%0.0%
Q3 2021$3,880,000
+7.0%
120,871
+12.8%
0.00%0.0%
Q2 2021$3,627,000
+10.6%
107,120
+22.8%
0.00%0.0%
Q1 2021$3,278,000
+30.0%
87,256
+15.0%
0.00%0.0%
Q4 2020$2,522,000
-9.3%
75,898
+0.1%
0.00%0.0%
Q3 2020$2,780,000
+3.4%
75,787
-7.2%
0.00%0.0%
Q2 2020$2,688,000
+51.7%
81,668
+19.0%
0.00%0.0%
Q1 2020$1,772,000
-16.1%
68,603
+1.2%
0.00%0.0%
Q4 2019$2,111,00067,7870.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 2,067,861$77,669,00045.24%
FRAZIER MANAGEMENT LLC 5,827,415$218,878,00017.56%
Abingworth LLP 1,203,135$45,057,00015.56%
Greenspring Associates, LLC 360,939$13,557,00010.78%
Penn Mutual Asset Management, LLC 86,940$3,265,0003.69%
RA Capital Management 3,115,008$117,000,0001.76%
Rhenman & Partners Asset Management AB 175,000$6,573,0000.46%
Summit Rock Advisors, LP 34,100$1,281,0000.44%
Eventide Asset Management 600,000$22,536,0000.33%
Parkman Healthcare Partners LLC 30,207$1,135,0000.26%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders